Friday, June 6, 2025

Monthly Archives: June, 2020

Breztri Aerosphere reduced rate of COPD exacerbations in Phase III ETHOS trial

June 24, 2020: "AstraZeneca’s triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) significantly cut the rate of moderate or severe exacerbations compared with two dual-combination therapies...

Coronavirus (COVID-19) Update: Daily Roundup June 24, 2020

June 24, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, FDA...

Difference between Investigator Brochure and Clinical Trial Protocol

In simple word, we can say that Investigator Brochure (IB) tells all about investigational product which is in clinical stage of development, whereas...

UK down-schedules Epidyolex to lowest level for controlled drugs

June 24, 2020: "The UK Home Office has reclassified Epidyolex (cannabidiol) as a Schedule 5 drug from its former classification as a Schedule 2...

New £1.3m national research programme to evaluate coronavirus tests

June 24, 2020: "Testing for coronavirus infection could become quicker, more convenient and more accurate, following the launch of a multicentre national programme of...

Novartis research shows technology talent increasingly drawn to pharma industry since COVID-19

June 24, 2020: "According to new research by Novartis, the healthcare and pharma industry has become a more desired career destination for tech talent...

Soleno Therapeutics Announces Proposed Public Offering of Common Stock

June 23, 2020: "Soleno Therapeutics announced that it intends to offer and sell shares of its common stock in an underwritten public offering.  In...

Coronavirus (COVID-19) Update: Daily Roundup June 23, 2020

June 23, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: In a...

IMBRUVICA® Seeks to Expand U.S. Label with Long-Term Data in Waldenström’s Macroglobulinemia

June 23, 2020: "AbbVie announced that the U.S. FDA will review a supplemental New Drug Application for IMBRUVICA® (ibrutinib) in combination with rituximab for the...

Gilead Sciences Secures Exclusive Option to Acquire Pionyr Immunotherapeutics

June 23, 2020: "Gilead Sciences, Inc. announced that for $275 million the company will acquire a 49.9 percent equity interest in Pionyr Immunotherapeutics Inc.,...

Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas

June 23, 2020: "Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have agreed...

EUROPEAN MEDICINES AGENCY VALIDATES APPLICATION FOR BAVENCIO® for UROTHELIAL CARCINOMA

June 22, 2020: "Merck and Pfizer Inc. announced that the European Medicines Agency (EMA) has validated for review the Type II variation application for BAVENCIO®...
- Advertisment -

Most Read